Publication | Open Access

Insulin-like growth factor receptor polymorphism defines clinical outcome in estrogen receptor-positive breast cancer patients treated with tamoxifen

Breast OncologyMedicinePathologyBreast CancerOncologyRadiation OncologyClinical OutcomeEndocrine-related Cancer